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く〉原著 original papers 
1) Okazaki T., Sakon S., Sasazuki T~， Sakurai H., Doi T., Yagita H., Okumura K. and Nakano 
H.: Phosphorylation of serine 276 is critical for p65 NF圃 itB subunit activation. Biochem. 
BiOphys. Res. Commun., 300: 807圃812, 2003. 
Abstract: Phosphorylation of several serine residues especially in the transactivation (TA) domain of p65 NF-KB 
subunit has been suggested to be important for its transcriptional activity. However, the responsible phosphorylation 
site of p65 remains controversial. To investigate the biological significance of phosphorylation and to determine the ｷ 
critical phosphorylation sites of p65, we reconstituted murine embryonic fibroblasts (MEFs）仕om p65（・／ー） mice with 
various serine to alanine (SA)-substituted mutants of p65. Unexpectedly, mutants in the TA domain, including 
S529A, S536A, and S529A/S536A, completely rescued the defect of p65（ー／ー） MEF s as assessed by tumor necrosis 
factor (TNF）ー ·or interleukin-I (IL・ 1 ）ーinduced IL-6 product~on' and protection from TNF-induced cel death. On the 
other hand, S276A mutant had an impaired ability to rescue these responses. Moreover, TNF・induced
phosphorylation of p65 was severely impaired in S276A mutant, indicating th瓜 S276 is the major phosphoryl~tion 
site of p65 and its phosphorylation is essential for p65-dependent cellular responses. 
2 ) . LeeS. J ., Saiki I., Haj叫正awa Y., Nunome S., Yamada H. and Kim S-H.: Antimetastatic and 
immunomodulating properties of a ne_w herbal prescription, Bojung-bangam圃tang. Inι 
1mmunopharmacol., 3: 147-157, 2003. 
Abstract: We investigated the antimetastatic effect of Bojung-bangam-tang, a new herbal prescription, on liver meｭ
tastasis by the inoculation of colon 26'・L5 carcinoma cells into the portal vein. Oral administration of Bojungｭ
bangam-tang for 15 days ｷfrom day 7 before 旬mor inoculation significantly inhibited liver metastasis in a doseｭ
dependent manner. Bojung-bangam-tang enhanced the mitogenic activity of BALB/c whole splenocytes induced by 
various mitogenic stimuli. Oral administration of Bojung-bangam-tang, by itself, could not induce the production of 
interleukin (IL):-12 or IFN” Y by macrophages, but enhanced the potential of macrophages to produce cytokines in reｭ
sponse to lipopolysaccharide (LPS). Experiments using macrophage-or natural killer (NK) cell-deficient mice reｭ
vealed that the antimetastatic effect of Bojung-batigam-tang is mediated by macrophages rather than NK cels. 
Bojung-bangam-tang caused a marked incr~ase of production of Thl cytokine (IFN帽の and decrease of production 
of Th2 cytokine (IL-4) by splenocytes stimulated with concanavalin A (Con A). These results indicated that oral adｭ
ministration of Bojung-bangam-tang inhibited the liver metastasis of colon 26-L5 cells through a mechanism leading 
to a Thl dominant immune state and activation of macrophages. Thus, Bojung-bangam-tang may be useful for the 
prevention of cancer metastasis. 
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3) Kangｷ I・C., Kim S-A., Song G.Y., Baek N圃I., Par~ Y.-D., Ryu S。 Y., S~iki I. and Kim S-H.: 
Effect of ethyl acetate fraction of Spatholobi Caulis on tumor cell aggregation and migration. 
Phytotheれ Res.-, 17: 163-167, 2003. 
Abstract: The ethyl acetate (EA）企action obtained 企om a methanol extract of Spatholobi caulis (Leguminosae) has 
been investigated for anti-metastatic activities in vi仕o. The EA 企action of Spatholobi caulis inhibited platelet aggreｭ
gation ’induced by B16BL6 melanoma cells with an IC(50) of 50 microgram/mL. The EA 企action significantly inｭ
hibited HT1080 cancer cell invasion through a ma住igeトcoatedfilter with an IC(50) of 25 microgram/mL. Messenger 
RNA expression of uP A was effectively decreased in HTI 080 cells by the EA 丘action of Spatholobi caulis with an 
IC(50) of 30 micrbgram/mL, but the expressions of MMP-2 (matrix metalloproteinase) and TIMPs (tissue inhibitors 
of metalloproteinases) were not changed. These findings indicated that the EA 企action suppressed tumour cell invaｭ
sion l:>y downregulation ofuPA(urokinase-type plasminogen activator). Taken together, these results suggest that the 
EA 合action ofSpatholobi caulis may have anti-metastatic activities by blocking 同mo町 cell-inducedplatelet aggreｭ
gation. (TCIP A) and tuni。ur cell invasion. 
4) Zhang H.W., Iida Y., Andoh T., Nojima H., Murata J., Saiki I. anｫIl Kuraishi Y.: Rapid 
Communication: Mechamcal hypersensitivity and alterations in cutane( us nerve fibers in a 
mouse model of skin cancer pain. J. Pharmacol. Sci., 91: 167・170, 2003。
Abstract: Melanoma inoculation induced marked mechanical allodynia and hyperalgesia in the periphery of the 
melanoma mass in mice from about day 10 post-inoculation. In the middle of the tumor, there were slight 
hyperalgesia and response disappearance in the early and late phases, respectively. PGP9.5-like immunoreactivities 
increased in the epidermis of the periphery of the 旬mor and disappeared 企um the dermis of the middle on day 18 
post-inoculation, without apparent alterations on day 10. When using this pain model, one should consider the ｷtumor 
site-dependent responses. 
5) Nakamura E. S., Koizumi K., Yamaura T. and Saiki I.: Anti-tumor angfog~nic effect of a ma..: 
trix metalloproteinase inhibitor MMI-270. Anticancer Res~， 23: 411・418~ 2003. 
Abstract: We investigated the anti-angiogenic effects of a matrix metalloproteinase inhibitor, (MMI), so . called 
MMI270, against Bl6-BL6 melanoma through the inhibition of the migrating and invasive abilities of hepatic sinu’ 
soidal endothelial (HSE) cells, as well as the formation of tube-like structures by HSE cells. MMI270, at the concenｭ
tration of 12.5 microgranis/ml, significantly inhibited the migration and invasion of HSE cells, in addition to tube 
formation by approximately 40%. Furthermore, the enzymatic degradation of metalloproteinases MMP・9 andMMP・
2 produced by HSE cells was inhibited by trea伽ient withｷ 1 microgram/ml of MMI270, showing 30% and 100% of 
inhibition in comparison to the control, respectively.-The intraperitoneal ｷadministration of MMI270 (200 mg/kg, 
twice daily for 8 days) after the implantation of Bl 6-BL6 melanoma cells into mice reduced the numb.er of vessels 
towards the established primary tumor on the dorsal side of mice. These results suggest that MMI270 might be useｭ
白l as an anti-tumor angiogenic drug. 
6) Terasaki K., Kanzaki T., Aoki T., Iwata K. and S~iki I: Effect of recombinant human tissue 
inhibitor of metalloproteinase-2 (rh-TIMP-2) on migration of epidermal lkeratinocytes in vitro 
ai:id wound healing in vivo. J. Dermatol., 30: 165-172, 2003. 
Abstract: Tissue inhibitors of metalloproteinases (TIMP), common inhibitors of matrix proteinases, have cell聞
promoting activity. We studied the effects of recombinant human tissue inhibitor of metalloproteinases・2 (rh-TIMP-
2) on the migration of normal human epidermal keratinocytes (NHEK). An in vitro migration assay revealed that rh・
TIMP・2 enhanced random migration (up to 170%, p<0.05) in a dose-dependent manner. When we applied rh白TIMP-
2 solution (20 microg/20 microl/wound) daily to full-thickness wounds made with an 8・mm punch on the backs of 
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healthy (n=8), aged (n=9), and diabetic (n=l5) ro~ents, we observed faster wound closure (p<0.05) than in vehicleｭ
treated controls. Accelerated wound closure was dose-dependent (0・20 microg/wound) in diabetic mice (n=6), and 
the optimal concentration was 10・20 microg of rh-TIMP・2/wound. Histological examinations performed on days 0, 
5, 10, 15, and 20 in diabetic mice revealed faster migration of epidermal keratinocytes 企omwound edges. These reｭ
sults suggest that rh-TIMP-2 plays an important role in wound healing. 
7) Kuraishi Y., Iida Y~， Zhang H-W., Uehara S., Nojima H., Murata J., Saiki I., Takahata H. and 
Ouchi l.: Suppression by Gabapentin of pain-related mechano・responses in mice given 
orthotopic tumor inoculation. Biol Pharm. Bull., 26 (4): 550・552, 2003. 
Abstract: In this s伽dy, we examined whether several types of non-opioid agents would inhibit the pain-related reｭ
sponses of melanoma-bearing mice. Orthotopic inoculation with melanoma into the hind paw induced marked tactile 
allodynia and mechanical hyperalgesia. A peroral injection (p.o.) of gabapentin (100-300 mg/kg) inhibited the 
allodynia and hyperalgesia, without effects on gross behaviors. An intraperitoneal injection (i.p.) of ketamine hydroｭ
chloride (30 mg/kg) produced partial inhibition in allodynia and hyperalgesia and prostate pos旬reat 15 min after inｭ
jection. Diclofenac sodium (10 and 30 ｷ mg/kg, i.p ), mexiletine hydrochloride (20 mg/kg, i.pよ clonidine
hydrochloride (0.1 mg/kg, i.p.) and suramin (100 mg/kg, i.p.) were without effects on allodynia and hyperalgesia. 
Subcutaneous in ections of baclofen (3 mg/kg) and N(G)-nitro-L-arginine methyl ester (100 mg/kg) were also withｭ
out e百ects. Repeated administration ofgabapentin (150 mg/kg, p・o.) produced constant inhibitions,ｷ suggesting no 
analgesic tolerance. Gabapentin may be use白l for the management of cancer pain. 
8) Nagaoka T., Banskota A.H., Tezuka Y., Harimaya Y., Koizumi K., Saiki I. and Kadota S.: 
Inhibitory effects of caffeic acid phenethyl ester analogues on experimental lung metastasis of 
murine colon26・L5 carcinoma cels.ｷ Biol. Pharm. Bull., 26: 638-641, 2003. 
Abstract：、 We have previously examined the antiproliferative activity of caffeic acid phenethyl ester (CAPE) and 
its 20 analogues against six tumor cel lines, and found that CAPE analogues possess selective antiproliferative acｭ
tivity toward the murine colon 26・LS carcinoma ceffline. To extend our study, the effects of CAPE analogues on 
the metastatic development o.f murine colon 26-L5 carcinoma cells in the lung were examined. The oral administraｭ
tion of CAPE (5 mg/niice/d) for 7 dafter tumor inoculation decreased the tumor weight and the number of tumor 
nodules in the lung by 50% and 50%, respectively, compared to the control, while CAPE (5 mg/mice/d) administered 
for 7 d before tumor inoculation showed no significant efect. Besides CAPE, 4・phenylbutyl caffeate, 8-phenyl-7幽
octenyl caffeate, 2・cyclohexylethyl caffeate and n-octyl caffeate at an oral dose of 2 mg/mice/d caused a 55%, 43%, 
55% and 35% reduction of the tumor nodules in their lung metastasis formation, respectively. These results further 
elaborate the possibility of CAPE and its ｷanafogues to become a new class of chemopreventive agents for the treatｭ
ment of colon cancer metastasis. 
9) Kanzaki Y., Onoue F., Sakurai H. and Ide T: Telomerase upregulates expression levels of 
interleukin (IL）・1α ， IL-1β ，IL・6, IL・8.,and granulocyte-macrophage colony-stimulating factor 
in normal human fibroblasts. Biochem. Biophys. Res. Commun., 305: 150・154, 2003 
Abstract: Expression of human telomerase reverse transcriptase (hTERT) in normal human fibroblast cel strain, 
TIG・3, extends their replicative life span. We found that expression levels of interleukin (IL）ー1α， IL・ 1J3, IL-6, IL・8,
and granulocyte-macrophage colony骨stimulating factor (GM-CSF) mRNA were up-regulated in hTERT-induced 
fibroblasts irrespective of population doubling level (PDL). Expression levels of these cytokines were low in growｭ
ing young TI G・3 cells and in control vector-transfected TIG・3 cels but were up-regulated in growth-arrested young 
cels maintained at high cel densitう人 In senescent TIG-3 cels, expression of IL-I J3, IL・6, and GM-CSF was moderｭ
ately increased. These results indicate that the introduction of h'(ERT into normal fibroblasts up-regulates the 
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expression of some inflammatory cytokines, and caution should be paid when introducing the hTERT gene to estabｭ
lish cell lines with normal phenoザpe.
10) Tsuchiya Y., Sawada S., Yoshioka I., Ohashi Y., Matsuo M., Harimay~ Y., Tsukada K. and 
Saiki I.: Increased surgical stress promotes tumor metastasis. Surgery, :Il3: 547・555, 2003. 
Abstract: BACKGROUND: Although it is well-known that excessive surgical s佐ess augments the growth of resid・
ual ca~cer and metastasis, whether surgical stress is i~creased according to the degree of surgical manipulation and 
can consequently lead to the enhancement of cancer metastasis has not been thoroughly examined. Moreover, the 
molecules associated with response for stress-enhanced metastasis have not been well-analyzed. The aim of this 
study was to examine whether cancer metastasis is enhanced with an increase of surgical stress with an experimental 
lung metastasis model and to analyzeJhe related mol~cules responsible for stress-enhanced metastasis. METHODS: 
Colon 26・LS carcinoma cells (1.5 x 104/mouse) were in ected intravenously into ふweek-old female BALB/c mice 
(Japan SLC, Hamamatsu, Japan). Two hours later, the mice were divided into 5 groups: untreated controls (the C 
group); mice given anesthesia only (the A group); mice given anesthesia and laparotomy (the AL group); mice given 
anesthesia, laparotomy, and appendectomy (the ALAp group); and mice given anesthesia, laparotomy, appendecｭ
tomy, and left hepatic lobectomy (the ALApH group). The anesthesia procedures were the same in al groups 
(intraperitoneal administration of 0.8 mg/mouse sodium pentobarbital). In the AL, ALAp, and ALApH groups, a 3・
cm long laparotomy was perfo~ed, and the time of the whole operation was just 5 minutes. All mice were killed 
14 days after the procedures, and the number of lung metastases on the lung surface was counted manually. At the 
same time, BALB/c mice without tumor burden were given the same 5 kinds of surgical stress, and the messenger 
RNA expression of various metastasis-related molecules in the lung was measured with reverse transcriptaseｭ
polymerase chain reaction at 6, 24, and 48 hours after surgical stress. We also examined the effect of ON0-4817 (an 
inhibitor of matrix metalloproteinases ([MPs]) on lung metastasis in the mice with the 5 kinds of surgical stres. 
RESULTS: The numbers offong metastases on the lung surface and the messenger RNA expression of MMP-9, 
membrane type IBMMP, and urokinase-type plasminogen activator 剖 24 hours after surgery were enhanced in pro司
portion to the degree of surgical stress. Moreover, ON0-4817 significantly inhibited lung metastasis. 
CONCLUSION: These results strongly suggest that increased surgical stress augments cancer metastasis via surgical 
stress-induced expression of proteinases in the target organ of metastasis. 
11) Koizumi K., Tsutsumi Y., Kamada H., Yoshioka Y., Watanabe M., Yamamoto Y., Okamoto 
T., Mukai. Y, Nakagawa S., Tani Y. and Mayumi T.: Incorporation ( f adult organ-derived 
endothelial cells info tumor blood vessel. Biochem. Biophys. Res. Commun., 306: 219・224,
2003. 
Abstract: In this s旬dy, we attempted to assess the mcorporable potential of vascular endothelial cells derived from 
adult organ blood vessels into tumor blood vessels. Two kinds of adult organ-derived vascular' endothelial cels, 
human aorta endothelial cells (HAEC) and umbilical vein endothelial cells (HUVEC), were administered into murine 
tumors inoculated to SCID mice. Many human blood vessel networks were visualized in the murine tumors. These 
cells in solid tumor not only survived、 andproliferated, but also inco中orated into 知mor endothelium. These results 
suggest that adult organ-derived vascular endothelial cells possess the potential to form the neovascular network in 
various tissues such as vascular endothelial progenitor-like cells in vivo. We propose that these cells can be regarded 
as a congenic (autologous) vector for vascular regeneration cell therapy and tumor vascular targeting gene therapy. 
12) Fujiuchi Y., Nagakawa 0., Murakami K., Fuse H. and Saiki I.: lEffect ~f hepatocyte growth 
factor (HGF) on invasion of prostate cancer cell lines. Oncol. Rep.。， 10: ll.001・1006, 2003. 
Abstract: Hepatocyte grow由 factor(HGF) was suggested to play an important role in the regulation of mitogenesis, 
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motogenesis, angiogenesis, migration and invasion for various 勿pes of cels, and acts through a specific membrane 
receptor encoded by c-met proto-oncogene. However, the mechanism of the effect of HGF on tumor invasion of 
prostate cancer cells remains unclear. We investigated the effect‘ of HGF on the invasion of PC-3 and DU・145 pros・
tate cancer cells through a reconstituted basement membrane (Matrigel), the haptotactic migration to fibronectin subｭ
strate, the expression of protein and mRNA for matrix metalloproteinases (MMP）・ 1 and ・9, membrane-type 1-MMP 
(MTl-MMP), urokinase-type plasminogen activator (u-PA) and its receptor (uPAR). HGF in~reased both Matrigel 
invasion and haptotactic migration of prostate cancer cels. Furthermore, HGF also increased the production of 
MMP-1 and ・9, MTl-MMP, u-PA apd uPAR of these cels. These results suggested that HGF increased the invasive 
potential of prostate cancer cells probably through enhancement of cell motility and the production of MMPs and uｭ
PA. 
13) Nakamura N., Ochi T., Sawada M., Tanaka H., Inagaki N., Saiki I and Nagai H.: Role of cells 
in IgE-dependent triphasic cutaneous reaction caused by dinitrofluorobenzene in the mouse 
ear: Participation of CD8+T cells. Allergology International., 52:31・36,2003.
Abstract: Background: previous studies have suggested that mice passively sensitized with anti-dinitrophenol 
(DNP) monoclonal IgE antibody exhibit a 仕iphasic cutaneous reaction with an immediate-pase response (IPR) at 1 
h, a late-phase response (LPR) at 24 h and a very late-phase reaction (vLPR) at 8 days after challenge with 2, 4-
dinitrofluorobenzene. The present study ~as conducted to evaluate the role of T cells in this triphasic cutaneous re鴫
action. Methods: Mice were passively sensitized by an intravenous in ection of anti-DNP monoclonal antibody. 
Allergic cutaneous reaction was caused by painting an antigen on the ears of mice and. measured an enlargement of 
the ears. Results: whereas the magnitudes of IPR and LPR in BALB/c nu/nu T cell-deficient mice were similar to 
those in BALB/c +/+ mice, vLPR was not observed in nu/nu mice. In addition, FK 506 (3 and 5 mg/kg) and 
cyclosporin A (30 and 50 mg/kg) clearly suppressed the onset of vLPR without affecting IPR and LPR. Because 
these findings suggest the participation of T cells in the on set of vLPR, the character of th己 T cells was investigated 
by using anti-CD4 or anti-CD8 monoclonal aritibo'dy (mAb) and interleukin (IL)-4 and IL-5 receptor a chain geneｭ
deficient mice~ When mice were treated with anti-CD4 or anti-CD8 mAb, the magni旬de of the vLPR was aug 
- 
mented by antiｷ 
gene slightly suppressed IPR,~ LPR and vLPR, but the lack of the IL-5Ra chain gene did not affect these triphasic 
responses. Conclusion: The present findings suggest that vLPR is mainly caused by CD8・positive T cels, probably 
Tel cels, and regulated by CD4・positive t cels. 
14) Matsuo M., Sakurai H. and Saiki I.: ZD1839, a selective epidermal growth factor receptor tyｭ
rosine kinase inhibitor, shows antimetastatic activity using a -hepatocellular carcinoma model. 
Mol. Cancer Theれ， 2: 557・561, 2003. 
Abstra~t: The epidermal growth factor receptor (EGFR) is highly expressed i~ many human tumors and provides 
a new target for anticancer drug development. EGFR-targeted agents have shown promising antitumor activity in 
preclinical and clinical trials. However, litle is yet known about the effect of these new agents on tumor metastasis. 
Here, we investigate the effects of ZD1839 (lressa), a selective EGFR tyrosine kinase inhibitor, on the metastatic 
properties of murineｷhepatocellular carcinoma CB0140C12. ZD1839 inhibited not only cel growth but also epiderｭ
mal growth factor-induced chemotactic migration and production 'Of active matrix metalloproteinase-9 in vitro. In 
mice, orthotopic implantation of a fragment of CB0140C12 tumor into the liver resulted in the formation of a soliｭ
tぽy tumor nodule and intrahepatic metastasis. ZD1839, given P・o., inhibited growth of the implanted tumor and' 
inttahepatic metastasis by approximately 50%. These results indicate that' EGFR signaling plays an important role 
in 旬mor metastasis and that ZD1839 is effective at inhibiting intral)epatic metastasis. 
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15} Lee S.J., Sakurai H.,Oshima K.,Kim S.H.,and Saiki I.: Anti-metastatk and anti-angiogenic 
activities of a new matrix metalloproteinase inhibitor, TN・6b. EUTroJ.Cancer, 39: 1632・
1641,2003. 
Abstract: We inve~tigated the anti-metastatic and anti-angiogenic effects of TN-6b, a new broad-spectrum inhibitor 
of matrix metalloproteinases (MMPs ),against Lewis lung carcinoma (LLC) and hepatic sinusoidal endothelial (HSE) 
cels. TN-6b potently inhibited the activities ofMMP-2 aild -9 secreted by LLC and HSE cells in a zymogram assay. 
TN~6b, at non-cytotoxic concentrations, caused a marked inhibition of invasion and migration of LLC, and tube-like 
formation of HSE cels. In con仕ast, TN” 6d, an inactive enantiomer of TN・6b, did not inhibit the invasion and tubeｭ
like formation. Daily subcutaneous (s.c.) administratio~ of TN・6b 剖 doses'of 30 and 60 mg/kg in mice resulted in 
a potent inhibition of tumour-induced angiogenesis of Bl6 melanomas and lymph node metastasis of LLC cels. In 
conclusion, TN・6b effectively inhibited lymph node metastasis of LLC cells through its anti-invasive and antiｭ
angiogenic properties. These findings suggest that the MMP inhibition correlates well with its anti-angiogenic and 
anti-metastatic efficacy and TN・6b has the therapeutic potential to inhibit angiogenesis and metastasis in vivo and 
in vitro. 
16) Yamamoto Y., Majima T., He J-X., Saiki I. and Tani T.: Chemicall and pharmaceutical 
evaluation of Daitou-Gancao in comparison with Chinese Glycyrr・rhizate Radix. J. Tad. Med., 
20: 102-110, 2003. 
17) Tran Q.L., Tran Q.K., Kouda K., Nguyen N.T., Maruyama Y.'J Saiki IT. and Kadota S.: A. 
Survey on agarwood in Vietnam. J. Tad. Med., 20: 124-131, 20030 
18) Yamamoto Y., Majima T., Saiki I .and Tani T.: Pharmaceutical evailUJlation of Glycyrrhiza 
uralensis roots cultivated in eastern Nei-Meng-Gu of China. Biol. Pharm. 'Bull., 26 (8): 1144-
1149,2003. 
Abstract: To clari命 the feasibility of medicinal use of the cultivated Glycyrrhiza resources, the equivalency beｭ
tween the G. uralensis roots cultivated in eastem-Nei・Meng-Guof China_ and medicinal licorice (Glycy町hizaeRadix, 
Gancao in Chinese and Kanzo in Japanese) was examined. The HPLC fingerprint including glycyπhizin (GL) of the 
cultivated roots was similar to that of medicinal Gancao, but different from that of non-medicinal Xinjiang-Gancao 
(Shin勾ro Kanzo in Japanese). Similarity between the cultivated roots and two medicinal Gancao was confirmed 
quantitatively by hierarchical cluster analysis on the basis of HPLC・7-peak-area data. Moreover, the 4-year-old adｭ
ventitious roots conformed to the five standards described、 in the Japanese Pharmacopoeia XIV (JP XIV). The 4-
year-old adventitious roots had similar pharmaceutical properties to those of medicinal Dongbei幽Gancao (Tohoku 
Kanzo in Japanese) as determined by examining IgE-mediated triphasic skin reaction in mice and pharmacokinetic 
profile of glycyrrhetic acid, an anti-allergic metabolite of GL. The present pharmaceutical study suggests that ,the 4・
year-old adventitious roots of G. uralensis cultivated in eastern Nei-Meng-Gu of China are comparable to medicinal 
Gancao conforming to the JP XIV, and may be a potential medicinal source to compensate for the insufficiency of 
wild Glycyrrhiza plants caused by collection restriction in China. 
19) Lee S-J., Ohashi Y., Sakurai H. Saiki I.: TAC・101 inhibits intrallntepatic metastasis of 
orthotopically implanted murine hepatocellular carcinoma. Cancer Letl.9 198: 169圃177, 2003. 
Abstract: The anti-metastatic effect of 4・［3,5・bis(trimethylsilyl)benzamido]benzoic acid (TAC-I 01) was investiｭ
gated using our established intrahepatic metastasis model. Orthotopic implantation of a fragment of CB0140C12 
hepatoma into the liver resulted in the formation of a solitary ttimor nodule and its intrahepatic metastasis. Daily oral 
administration of TAC・101 at a dose of 8 mg/kg resulted iJ?. a significant inhibition of intrahepatic metastasis, but 
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did not affect the growth of the-tumor at the implanted site .The down闘regulation of transcriptional anti-activator 
protein-I (AP-1) activity by TAC幽101 paralleled the inhibition of cel invasion and migration through the repression 
of expression of the mRNAs for urokinase-type plasminogen activator (u-PA) and its receptor (u・PAR). These findｭ
ings suggest that TAC-I 01may improve therapeutic efficacy for liver cancer patients to prevent in仕ahepaticmetasｭ
tasis. 
20) Nagakawa 0., Fujiuchi Y., Fuse H. and Saiki I.: Differential effect of chromogranin A frag圃
ments on invasion-and growth of prostate cancer in vitro. Urology, 62: 553；・558, 2003. 
Abstract: OBJECTIVES: To investigate the effect of various chromogranin A (CgA）企agments on the invasion, 
haptotactic migration, and growth of prostate cancer cels. METHODS: We investigated the. effect of five kinds of 
CgA 企agments (79-115, 286-301, 324・341, 344-374, and 356幽374) on the invasion of PC-3 and DU・145 prostate 
cancer cells through a reconstituted baseme11_t membrane (matrigel) and the haptotactic migration of these cels using 
a Transwell cell culture chamber assay. Cell growth was assessed by the WST-1 Cell Counting Kit. RESULTS: CgA 
(79・ 115) inhibited the invasive ability of PC-3 and DU・145 cells （~ = 0.035 and P = 0.037, respectively). CgA (79・
115) also inhibited the haptotactic migration of these cels (P = 0.031 and P = 0.021 ).On the other hand, other CgA 
fragments had no significant efect. CgA (79」 15) also inhibited the cel growthｷ of PC-3 cells (P = 0.012) and DU・
145 cels (P < 0.001). CgA (324・341), CgA (344-374), andCgA (356・374) inhibited the cel growth of DU咽 145 cels 
(P < 0.001, P < 0.001, and P < 0.001, respectively). CONCLUSIONS: These results indicate that some CgA 合ag­
ments may affect the invasion and growth of prostate cancer cels. 
21) Huh J-E., Kang k圃S., Ahn K-S., KimｷD-H., Saiki I. and Kim s・H.: Mylabris phalerlata inｭ
duces apoptosis by caspase activation following cytochrome c release ｷand Bid cleavage. Life 
Sci. 73: 2249~2262, 2003. 
Abstract: Mylabris phalerata (MP) is an insect that has been used for the treatment .of cancer in oriental medicine. 
In the present s旬dy, the butanol (BuOH) fraction of MP (BFMP) was examined to determine whether it can exert 
anti-cancer activity through an apoptotic pathway with litle toxicit)人 BFMP was found to have a ｷspecific cytotoxic 
effect on human monocytic leukemic U937 cells (IC(50) = 140 microg/ml) rather than on peripheral blood monoimｭ
clear lymphocytes (PBML, IC(50) = over 500 microg/ml). BFMP also induced the morphological changes of 
apoptosis, such as chromatin condensation, cel shrinking and DNA fragmentation at a concentration of 31.25 
microg/ml. In addition, BFMP significantly increased the portion of apoptotic annexin-V positive cels in a doseｭ
dependent manner, and effectively activated caspases (cysteine aspartase) cascade involving caspases 8, 9 and 3. 
BFMP also effectively cleaved Bid, a death agonist member of the Bcl-2 family and (poly(ADP-ribose)polY.merase) 
(P ARP) and induced the subsequent release of cytochrome c from mitochondria into the cytosol. However, it did not 
affect Bcl-2 and Bax expression. Taken together, these data SlJggest that the BuOH extract of Mylabris phalerata can 
induce apoptosis in U937 cells by caspase cascade activation in conjunction with cytochrome c release, induced by 
a product of Bid. Therefore, we conclude that BfMP has anti-cancer activity, which is achieved through apoptosis 
and is associated with litle toxicity. 
22) Sakurai H., Suzuki S., Kawasaki N;, Nakano H., Okazaki T刊 Chino A., Doi T., Saiki I.: TNF岨
α 圃induced IKK phosphorylation of NF・ κB p65 on serine 536 is medicated through TRAF2, 
TRAF5 and TAKI signaling pathway. J Biol. Chem., 278: 36916圃36923, 2003. 
Abstract: The activation of NF ,.K]3 has been shown to be regulated by multiple phosphorylations oflkappaBs and 
the NF-KB p65 ｷsubunit. Here, we characterized the intracellular signaling pathway leading to phosphorylation of p65 
on Ser-536 using a novel anti-phospho・p65 (Ser-536) antibody. The Ser-536 of endogenous p65 was rapidly 
pl;losphorylated in response to a wide variety of NF-KB stimulants including TNF-alpha in.the. cytoplasm and rapidly 
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dephosphorylated in the nucleus. The TNF－α－but not IL・ 1beta-induced Ser-536 phosphorylation was severely imｭ
paired in murine embryonic fibroblasts derived 仕om traf2：・／・traf5・／－ mice. Bay 11-7082, an inhibitoF of IKB 
phosphorylation, inhibited the TNF－α－induced phosphorylation in vivo. In addition, overexpression of TGF－~・
activated kinase 1 (TAKl), IKKαand IKK~ stimulated the phosphorylation, and .their dominant negative mutants 
blockedthe TNF－α－induced phosphorylation. Moreover, small interfering RNAs (siRNAs) against TAKl,IKKαand 
IKK~ blocked the phosphorylation of endogenous p65. On the other hand, calyculin-A, a protein phosphatase inhibiｭ
tor, blocked the dephosphorylation in the nucleus in vivo. These results indicate that similar signaling pathways were 
utilized for the phosphorylations of b.:Balpha and p65, which further support the idea that both IKB and NF-KB are 
substrates for the IKK complex in the activation of NF-KB. 
23) Koizumi K., Tsutsumi Y., Yoshioka Y.，明＇atanabe M., Okamot( T., Mukai Y吋 Nagakawa S 
and Mayumi T.: Anti-angiogenic effects of dimethyl sulfoxide on elllldothelial cells. Biol. 
Pharm. Bull., 26: 1295・1298, 2003. 
Abstract: Dimethyl sulfoxide (DMSO) has anti-inflammatory and analgesic properties and is the only intravesical 
agent approved by the FDA for the treatment of interstitial cystitis. While it is known that DMSO has numerous bioｭ
logical effects on cel differentiation and alteration of cell-surface carbohydrate structures, the anti-inflammatory 
mechanism of DMSO has been not clear yet. Therefore, further investigation of DMSO in terms of inflammation 
therapy is needed. This study assessed the in vitro anti..;angiogenic effects of DMSO on human aorta endothelial cells 
to clari今 one of the mechanisms of its anti-inflammatory activity. DMSO did not affe~t expression of E嗣selectinon 
endothelial cells in the presence of TNF－α. Furthermore, DMSO effectively inhibited capillary tube formation; this 
mechanism wo:uld be due to suppression of matrix metaUoproteinase-2 (MMP・2) production. These results provide 
useful knowledge about the anti-inflammatory effects of DMSO and the regulatory mechanism of MMP之
24) Sano K, Takayama T, Murakami K, Saiki I, Makuuchi M.: Overexpre~sion of :retinoic acid 
receptorαin hepatocellular carcinoma. Clin. Cancer Res. 9: 3679圃36839 2003. 
Abstract: PURPOSE: Retinoid analogues have been reported to inhibit the growth of hepatocellular carcinoma 
(HCC} However, the expression profile of retinoic acid rec~ptors (RARs) in HCC has not been fully clarified. In 
this s同dy, we investigated the expression of RAR mRNAs and proteins in resected HCC and nontumor liver tissue. 
EXPERIMENTAL DESIGN: Reverse transcription-PCR and Western blot analysis were applied to investigate the 
expression of RAR mRNAs and proteins in -32 resected s.amples of HCC and 14 samples of nontumor liver tissue. 
A HCC cel line and primary-cultured hepatocyte were treated with RAR－α－selective retinoids i_n vitro to estimate 
their an~iproliferative activity. RESULTS: The intensities of mRNA and protein for RAR田αinHCC tissue were sigｭ
nificantly higher than those in nontumor liver tissue (P = 0.002 and P = 0.002, respectively). The intensity ratios of 
HCC versus nontumor liver for RAR·αmRNA and protein were significantly .higher than those for RAR帽p and 
RAR-y (mRNA, P = 0.02 and P = 0.006; protein, P = 0.04 and P = 0.007, respectively). There was only one signifiｭ
cant correlation between the higher intensity of RAR-beta protein and tumor stage (stage-I/II versus stage III/IVA, 
P = 0.01) among clinicopathological variables in the HCC patients. However, in vitro experiments showed that the 
growth of a RAR－α－elevated HCC cel line was potently inhibited by treatment with retinoids at concentrations that 
did not affect the growth of primary” cultured hepatocytes. CONCLUSIONS: These results imply that RAR鴫αis the 
dominant receptor in HCC, which suggests that RAR－α－selectiVe retinoid analogues may be useful for chemotherｭ
apy. 
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25) Ueda J.Y., Tezuka Y., Banskota A.H., Tran Q.L., Tran Q.K, Saiki I., Kadota S.: 'Constituents 
。fthe Vietnamese medicinal plant Streptocaulon juventas and their antiproliferative activity 
against the human HT・1080 fibrosarcoma cell line. J. Naι Prod. 66: 1427-33, 2003. 
Abstract: The methanolic extract of roots of S仕eptocaulonjuventas, having shown s仕ong antiproliferative activity 
against the highly metastatic human HT-1080 fibrosarcoma cel Jine, was subjected to activity-guided isolation to 
yield 16 cardenolides including five new ones, acovenosigenin A 3-0・beta-digitoxopyranoside ( 1 ),digitoxigenin 
gentiobioside (2), digitoxigenin 3-0・［O・beta-glucopyranosyl・(1ー＞6)-0・beta-glucopy!anosyl・(1 ー＞4｝・3・0・acetyl­
beta-digitoxopyranoside] (3), digitoxigenin 3 ・0・［O・beta-glucopyranosyl-( 1 ー＞6）ー0・beta-glucopyranosyl・(1-->4）一o鵬
beta-digitalopyranosyl-( 1 ー＞4）・・beta-cymaropyranoside] ( 4),and periplogenin 3-0・（4-0-beta..:glucopyranosyl・beta­
digitalopyranoside) (5), and two new hemiterpenoids, (4R)-4・hydroxy~ふisopropylpentylbeta-rutinoside (6) and (R）・
2・ethyl-3・methylbutyl beta-rutin9side (7), together with two known phenylpropanoids.and a known phenylethanoid. 
The isolated cardenolides strongly inhibited the proliferation of the HT・1080 cel line (IC(50) values, 54・ 1600 nM). 
26) Ueda J., Tezuka Y., Banskota A.H., Tran Q.L., Tran Q.K.,. Saiki I. and Kadota S.: 
Antiproliferative activity of cardenolides isolated from Streptocaulon juven仰s. Biol. Pharm. 
Bull., 26: 1431-1435, 2003. 
Abstract: Sixteen cardenolides, two hemiterpenoids, two phenylpropanoids and a phenylethanoid isolated 企omthe 
roots of Streptocaulon juventas (LOUR.) MERR. were examined for their antiproliferative activity toward three huｭ
man-derived (HT-1080 fibrosarcoma, lung A549 adenocarcinoma, cervix HeLa adenocarcinoma) and three murineｭ
derived (colon 26-L5 carcinoma, Lewis lung carcinoma, B 1ふBL6 melanoma) cel lines. The cardenolides 
selectively and strongly inhibited proliferation of the HT~1080 (IC(50) values, 0.054・ 1.6microM) and A549・ (IC(50),
0.016・0.65 microM）、cell lines. The characteristic morphological changes and ladder-like DNA fragmentation in 
those cels treated with the cardenolides indicated the antiproliferative activity was due to the induction of apoptosis. 
27) F吋ita F., Delhase M., Taniguchi Y., Narita Y., Kato T., Furuya A., Ogawa T., Sakurai H., 
Joh T., Itoh M., Karin 酢I. and Nakanishi M.: Identification of NAPl: a regulatory subunit of 
IKK-related kinases that activates NF-KB signaling. Mo/. Cel. Biol., 23: 7780・7793, 2003. 
Abstract: The IKB kinase (IKK)-related kinase NAK (also known as TBK or T2K) contributes to the activation of 
NF-KB－・dependent gene expression. Here we identi今 NAPl (for NAK-associated protein 1), a protein th剖 interacts
with NAK and its relative IKK varepsilon (also known as IKKi). NAPl activateｷs NAK and facilitates its 
oligomerization. Interestingly, the NAK-NAPl complex itself effectively phosphorylated serine 536 of the p65/RelA 
subunit of NF-KB, and this activity was stimulated by 旬mor necrosis factor alpha (TNF・α）. Overexpression of 
NAP 1 specifically enhanced cytokine induction of an NF-KB-dependent, but not an AP・トdependent, reporter. 
Depletion of NAPl reduced NF-KB-dependent reporter gene expression and sensitized cels to TNF－α－induced 
apoptosis. These results define NAPl as an activator of IKK-related kinases and suggest that the NAK四NAPl comｭ
plex may protect cells from TNF－α－induced apoptosis by promoting NF-KB activation. 
28) Ueda Y., Yamagishi T., Samata K., Ikeya H., Hirayama N., Takashima H., Nakaike S., 
Tanaka M., and Saiki I.: A novel low molecular weight antagonist of vascular endothel,ial 
growth factor receptor binding: VGF1155. Mol. Cancer Theん 2: 1105・1111, 2003. 
Abstract: Vascular endothelial growth factor (VEGF) plays a pivotal role in the processesｷof angiogenesis, which 
is essential for the growth of solid tumors and their metastasis .Because VEGF is a critical factor in tumor survival, 
inhibiting VEGF would provide significant benefits in 制mortherapy. To identi命 acompound that inhibits the bindｭ
ing of VEGF to its receptor, we used a high throughput screening method, finding that small molecular compounds 
inhibited VEGF binding. Among active compounds, 5-[N-methyl-N-(4-octadecyloxyphenyl)acetyl]amino之”
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methylthiobenzoic acid (VGAI 155) was selected for its potent inhibition of binding. VGAI 155 inhibited [(125)1] 
VEGF bindin~ to two cel lines, NIH3T3-fms-like tyrosine kinase-I {VEGF receptor 1 仕組sfected) cells and 
NIH3T3-kinase insert domain containing receptor/fetal liver kin.ase-1 (KDR/Flk~・ 1; VEGF receptor 2 transfected), in 
a concentration-dependent manner. VGAI 155 did not inhibit the binding of several other gro~h factors or cytokines 
to their receptors. Based on the results of surface plasmon resonance analysis using Biacore S51 system, it appears 
that this binding inhibitory property may be based on the association OfVGAl 155 with VEGF receptor 2 (KDR/Flk-
1). Further, the interference in VEGF binding by VGAI 155 in tum induces the 、inhibition of VEGF-induced 
KDR/Flk-1 autophosphorylation. VGAI 155 also reduced intraderrnal VEGF-induced vascular permeability in 
guinea pigs. These findings indicate that VGAI 155 inhibits not only VEGF binding to its rec~ptors through associaｭ
tion with KDR/Flk-1 but also VEGF function in vivo. These VGAI 155 activities may provide a useful basis for the 
development of antiangiogenic and anti tumorｷ agents. 
29) Ohashi Y., Tsuchiya Y., Koizumi K., Sakurai H. and Saiki I.: Preveiltim1 of intrahepatic me-
tastasis by curcumin hi an orthotopic ｷimplantation model. Oncology, 65: 250-258, 2003. 
Abstract: Curcumin has< been shown to have potent anti-metastatic activity, however, its mechanism of action is 
stil unclear. Here, we analyzed the anti-metastatic mechanism using hepatocellular carcinoma, CB0140C12 cels. 
Daily oral administration of curcumin suppressed in甘ahepatic metastasis in a dose-dependent manner, whereas the 
growth of implanted tumors was not affected. We next examined the effect of curcumin on several metastatic propｭ
ertiesin vitro. Curcumln inhibited the invasion of tumor cells through Matrigel-coated filters and the production of 
MMP-9. In addition, curcumin significantly inhibited adhesion and haptotactic migration to fibronectin and laminin 
without affecting the expression of integrins on the cell surface. Furthermore, the formation of actin stresｷ fibers was 
affected by treatment with curcumin. These results suggested that curcumin suppressed the intrahepatic metastasis 
mediated by the inhibiton of several metastatic properties, in which the functional alteration of cytoskeletal organiｭ
zatioil, at least in part, could play an important role. 
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1 ）永井博弐：岐阜薬科大学薬理学，「アトピー性皮膚炎モデルにおける伝統薬物の効果」， 1994, 4~ 
2 ）加藤敏光：大日本インキ化学工業（株），「藍藻スピルリナ成分の抗転移・抗アレルギ一作用に関する研
究」， 1996, 3~ 
3 ）岩崎輝明：玄米酵素（株），「FBI~A の経口投与によるマウスリンパ球の増殖及びサイトカイン産生に
及ぼす効果」， 2002, 4~ 
く〉非常勤講師
。済木育夫：富山医科薬科大学医学部専門教育講義「免疫学」， 2003, 01, 07，富山．
2 ）済木育夫：富山医科薬科大学大学院医学系研究科修士過程講義「東洋医学概論」， 2003, 12, 10，富山．
3 ）済木育夫：富山医科薬科大学薬学部専門教育講義「薬理学E」， 2003, 12, 12，富山；
く〉研究費取得状況 Acquisition of research funds 
1 ）文部省科学研究費，特定領域研究 c ( 1) （分担：済木育夫）「制癌剤スクリーニング」，（分担課題）基
底膜浸潤阻害物質の検定






5 ）平成14年度上原記念生命科学財団研究助成金（代表〈棲井宏明）「新しい NF－ κB 活性化機構： RelA リ
ン酸化に関する研究」






9 ）平成15年度21世紀 COE プログラム「東洋の知に立脚した個の医療の創生」（分担：済木育夫）臨床研
究（遺伝子多型と血衆フ。ロテオーム解析）









受託研究員：谷山光曹、（株ツムラ， 2003. 04.~:2004. 03.) 
学内研究生：永川 修（富山医科薬科大学医学部・泌尿器科学， 2003, 4~) 
小尾龍右（富山医科薬科大学医学部・和漢診療学， 2003, 4:~) 
藤内靖喜（富山医科薬科大学医学部・泌尿器科学教室， 1999., 4~) 
明石拓也（富山医科薬科大学医学部・泌尿器科学教室， 2002., 4~) 
薄田勝男（富山医科薬科大学附属病院・光学医療診療部， 2002, 1~) 
地野充時（富山医科薬科大学医学部・和漢診療学， 2002, 4~) 
吉岡伊作（富山医科薬科大学医学部・第二外科， 2,002, 4~) 
外国人客員研究員：
81 
Lee Soo-Jin I李秀員（Graduate School of East-West Medical Sciences, Kyung Hee University, 
2001, 06. 01 ~ 2003., 03. 10) 
Choo Min-k卯ng I秋文京（K戸時 Hee University, Collage of Pharmacy, 2002, 09. 25~ 2003. 
03. 31) 
Leena Suntomsuk (Faculty of Pharmacy, Mahidol Iniversoty, 2003. 08. 01 ~ 2003. 09. 30) 
Pongpun Siripong (Natural products research Section, Research Division, National Cancer Institute, 
Bangkok, 2003, 1. 01 ~ 2002. 12. 30) 
Kriengsak Lirdprapamongkol (Laboratory, of Biochemistry, Chulabhom Research Institute, 2003, 
10. 01 ~ 2002. 12. 25) 
研究所研究生：
Pattama Singhirunnusom (Mahidol University, 2002, 10. 02~ 2003, 03. 31) 
く〉学位（修士，博士）取得者 Academic degrees and theses 
卒業論文：
鈴木俊輔： NF－ κB p65サブユニット Ser-536のリン酸化および脱リン酸化の解析
修士論文：






巽武司： Immunological properties of Oren-gedoku-to (a Kampo medicine, Huang-Lian-Jie-Du・Tang) on 
contact hypersensitivity reaction in mice. 
医学博士（富山医科薬科大学）
溝口和巨： Mechanism of chronic stress-induced depression-likeｷ disorder: dysfunction of the hypothalamo・








林和子：本学技官退官（2003. 03. 31) 
寺林昌代：非常勤職員（2003. 04. 01~) 
木我千鶴：研究協力員（富山県新世紀産業機構派遣研究員， 2003.11.01～）
